Product Code: RP-ID-10070777 |
Published Date: 21 Mar 2025 |
Region: Global |
Category: Healthcare & Pharmaceuticals |
Report ID: 10070777
Market Overview:
Cell Banking Outsourcing Market Segmentation by Bank Type (Master Cell Banking, Viral Cell Banking, and Working Cell Banking); by Product (Cord Cell Banking, Adult Cell Banking, IPS Stem Cell Banking, and Others); by Cell Type [(Stem Cell Banking (Cord Cell Banking, Adult Stem Cell Banking, IPS Stem Cell Banking, and Embryonic Stem Cell Banking) and Non-Stem Cell Banking)]; and by Bank Phase (Bank Storage, Bank Preparation, Bank Characterization, and Bank Testing)-Global Demand Analysis & Opportunity Outlook 2031
Global Cell Banking Outsourcing Market Highlights Over 2022 – 2031
The global cell banking outsourcing market generated the revenue of approximately USD 7200.1 million in the year 2021 and is expected to garner a significant revenue by the end of 2031, growing at ~18% CAGR over the forecast period, i.e., 2022 – 2031. The growth of the market can primarily be attributed to the development of advanced preservation techniques for cells and the increasing adoption of regenerative cell therapies for the treatment of chronic diseases such as cancer. Additionally, factors such as growing demand for gene therapy, and stem cell therapy, increasing biopharmaceutical production, and increasing prevalence of oncology-associated diseases and other infectious chronic disorders are expected to drive market growth. According to Health Resources & Service Administration, 4,275 cases related to bone marrow and cord blood transplants were performed in the United States, in the year 2018.
CLICK TO DOWNLOAD A SAMPLE REPORT
Cell banking is the process of procuring stem cells from the human body followed by processing and storing of the cells for potential use in future treatments. Cells are primarily utilized in the production of regenerative medicines. The cell banks provide storage for cells with an elaborate characterization of the entire cell line as it reduces the possibilities of cross-contamination. Furthermore, the process of the cell storage first requires proliferation of cells, which gets multiplied in a large number of identical cells and is then stored safely for future requirements.
The global cell banking outsourcing market is segmented by bank type, product, cell type, and bank phase. The bank phase segment is further divided into bank storage, bank preparation, bank characterization and bank testing. Among these segments, the bank storage segment held largest market share in the year 2021 and is expected to maintain its share by growing with a notable CAGR during the forecast period. The market growth is anticipated to be driven by the development of effective preservation technologies such as cryopreservation technique. Cryopreservation is a technique in which low temperature is used to preserve the living cells and tissue for a longer time period.
Global Cell Banking Outsourcing Market Regional Synopsis
Regionally, the global cell banking outsourcing market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in North America region held the largest market share in terms of revenue in the year 2021. The growth of the market in this region is majorly associated with the increasing number of pharmaceutical companies & manufacturers in the region and increasing awareness for the use of stem cells as therapeutics. Alternatively, the market in the Asia Pacific region is anticipated to grow with the highest CAGR during the forecast period. The market in this region is driven by the increasing investment in biotechnology sector by government and private companies specifically in countries such as China, India, and Japan. Moreover, the increasing pool of patient with chronic diseases, such as cancer, and the ongoing research & development activities for cancer treatment is expected to show growth in the market. As sourced from the Asia Diabetes Prevention Initiative, around 60% of the diabetic population reside in the Asia Pacific region.
Market Segmentation
Our in-depth analysis of the global cell banking outsourcing market includes the following segments:
By Bank Type
-
Master Cell Banking
-
Viral Cell Banking
-
Working Cell Banking
By Product
-
Cord Cell Banking
-
Adult Cell Banking
-
IPS Stem Cell Banking
-
Others
By Cell Type
Stem Cell Banking
-
Cord Cell Banking
-
Adult Stem Cell Banking
-
IPS Stem Cell Banking
-
Embryonic Stem Cell Banking
Non-Stem Cell Banking
By Bank Phase
-
Bank Storage
-
Bank Preparation
-
Bank Characterization
-
Bank Testing
Growth Drivers and Challenges Impacting the Growth of the Global Cell Banking Outsourcing Market
Growth Drivers
-
Increasing prevalence of chronic diseases
-
Growing demand for gene therapy
-
Growing awareness about stem cell banking
-
Supportive initiatives by government
Challenges
-
High cost of treatment
-
Contamination of cell lines during the storing process
-
Non-availability of donors
Key Companies Dominating the Global Cell Banking Outsourcing Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global cell banking outsourcing market that are included in our report are SGS SA, WuXi AppTec, LifeCell International Pvt. Ltd., BSL Bioservice, LUMITOS AG, Cryo-Cell International, Inc., REPROCELL Inc, CORDLIFE GROUP LIMITED, Reliance Life Sciences, and Clean Biologics among others.
Latest Developments in the Global Cell Banking Outsourcing Market:
-
7 April 2017: Cryo-Cell International announced the launch of an innovative solution called “five-chamber cord blood freezer” which will provide an opportunity to parents and doctors where a newborn’s stored cord blood stem cells can be used more than once for treatment.
-
24 March 2021: LifeCell announced the launch of one-of-a-kind service for its community members named “StemMatch”. The agenda of StemMatch is to provide information about the quality and quantity of stem cells available for a successful blood stem cell transplant.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis, and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
- SGS SA
- WuXi AppTec
- LifeCell International Pvt. Ltd.
- BSL Bioservice
- LUMITOS AG
- Cryo-Cell International.Inc.
- REPROCELL Inc
- CORDLIFE GROUP LIMITED
- Reliance Life Sciences
- Clean Biologics
Related Reports
Proof of Quality & Reliability
